Sutaria Saumya
CEO
Sutaria Saumya has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company, with disclosures dating back to 2025. 5 of those filings fall inside the rolling window. Most recent filing: Aug 27, 2026.
On the most recent filing, Sutaria Saumya is listed as CEO at TENET HEALTHCARE CORP. Inside the rolling window, Sutaria Saumya reported no open-market purchases and 2 open-market sales totaling $27.6M in THC. The largest disclosed transaction in the window is a sale of 50,000 THC shares on Aug 24, 2026, worth $13.9M.
Companies traded
Other insiders at THC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$27.6M
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
Frequently asked questions
How many SEC Form 4 filings has Sutaria Saumya made?
Sutaria Saumya has filed 7 SEC Form 4 filings (19 transaction rows) across 1 company since 2025.
Which companies does Sutaria Saumya trade?
Sutaria Saumya has filed SEC Form 4 disclosures for 1 company, including THC.
When was Sutaria Saumya's most recent SEC Form 4 filing?
Sutaria Saumya's most recent SEC Form 4 filing on Tracefour is dated Aug 27, 2026.
What is Sutaria Saumya's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Sutaria Saumya is listed as CEO.
What is Sutaria Saumya's total buy and sell value in the current window?
Inside the rolling retention window, Sutaria Saumya bought $0 and sold $27.6M based on SEC Form 4 filings.
What was Sutaria Saumya's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 50,000 THC shares on 2026-08-24, worth $13.9M, per SEC Form 4 filings.